Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents

After becoming aware of international reports about neurological side effects, such as anxiety, panic reaction, visual hallucinations and seizures, possibly associated with melatonin use in children and adolescents ranging from newborn to 18 years old (pediatric population), Health Canada did a review of this safety issue in this age group.

Données et ressources

Info additionnelle

Champ Valeur
Source
Version
Producteur
Courriel de l'auteur
Mainteneur
Courriel du mainteneur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Résumé de l'examen de l'innocuité - MÉLATONINE (N-acétyl-5-méthoxytryptamine) - Examen de l'innocuité de la mélatonine chez les enfants et les adolescents
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Langue
Contact Person
Contact Email
Dictionnaire de données
Open Canada Date Published 2020-12-07 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Examen sommaire de l'innocuité", "Loratadine", "rythme cardiaque anormal", "allongement de l'intervalle QT", "utilisation de produits médicamenteux en vente libre"], "en": ["Summary Safety Review", "MELATONIN", "N-acetyl-5-methoxytryptamine", "review of safety", "Melatonin-use in Children-and-Adolescents", "neurological side effects", "anxiety", "panic reaction", "visual hallucinations", "seizures"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source